Gilead Sciences
GILD
1,564 hedge funds and large institutions have $70.1B invested in Gilead Sciences in 2021 Q3 according to their latest regulatory filings, with 122 funds opening new positions, 618 increasing their positions, 593 reducing their positions, and 83 closing their positions.
47% more first-time investments, than exits
New positions opened: 122 | Existing positions closed: 83
1% more funds holding
Funds holding: 1,546 → 1,564 (+18)
4% more repeat investments, than reductions
Existing positions increased: 618 | Existing positions reduced: 593
2% more capital invested
Capital invested by funds: $68.5B → $70.1B (+$1.61B)
0.73% more ownership
Funds ownership: 79.35% → 80.09% (+0.73%)
3% less call options, than puts
Call options by funds: $1.62B | Put options by funds: $1.67B
3% less funds holding in top 10
Funds holding in top 10: 32 → 31 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dodge & Cox
San Francisco,
California
|
+$583M |
| 2 |
Two Sigma Advisers
New York
|
+$330M |
| 3 |
Morgan Stanley
New York
|
+$310M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
+$228M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$197M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$198M |
| 2 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$182M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$182M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$149M |
| 5 |
MWNA
Marshall Wace North America
New York
|
-$128M |
GILD Hedge Fund Activity: Q3 2021 in Review
1,564 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q3 2021, worth a combined $70.1B — up 2.4% from $68.5B a quarter earlier.
Buyers outnumbered sellers: 122 funds opened new GILD positions and 83 closed out — a net gain of 39 holders — while 618 added to existing stakes and 593 trimmed.
The largest buyer was Dodge & Cox, adding an estimated $583M. The largest seller was BlackRock, cutting an estimated $198M.
- 1,564 institutional investors held Gilead Sciences (GILD) as of Q3 2021, up from 1,546 in Q2 2021.
- Funds reported $70.1B of Gilead Sciences stock for Q3 2021, up 2.4% quarter-over-quarter.
- 122 funds opened new Gilead Sciences positions in Q3 2021 and 83 closed out, a net change of +39 holders.
- The largest Gilead Sciences buyer in Q3 2021 was Dodge & Cox, an estimated $583M added.
- The largest Gilead Sciences seller in Q3 2021 was BlackRock, an estimated $198M sold.
Based on aggregated 13F filings for Q3 2021.